Navigation Links
Vermillion Announces Receipt of NASDAQ Panel Decision
Date:9/25/2008

FREMONT, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced that it has received notification from The NASDAQ Stock Market LLC that the NASDAQ Listing Qualifications Panel has determined to delist the Company's securities from The NASDAQ Capital Market, effective as of the open of business on Thursday, September 25, 2008. The delisting is the result of the Company's noncompliance with the minimum stockholders' equity requirement for continued listing on The NASDAQ Capital Market, as set forth in Marketplace Rule 4310(c)(3).

The Company has been advised that its securities are immediately eligible for quotation in the Pink Sheets, an electronic quotation service for securities traded over-the-counter, effective as of the open of business on Thursday, September 25, 2008. The Company's shares will continue to trade under the symbol VRML. In addition, the Company has been advised that a Market Maker is filing the necessary application with the Financial Industry Regulatory Authority ("FINRA") to quote the securities and as a result we anticipate in the near future that the Company will be quoted on the Over-the-Counter Bulletin Board (the "OTCBB").

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion and Stanford Scientists Receive Best Research Award From the PAD Coalition
2. Vermillion Retains ThinkPanmure to Assist in the Evaluation of Potential Strategic Alternatives
3. Vermillion to Host Live Roundtable Discussion With Principal Investigator of OVA1(TM) Submission
4. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
5. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
6. Vermillion Announces Appointment of John Hamilton to Board of Directors
7. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
8. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Announces Effectiveness of Reverse Stock Split
11. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Hunting Valley, Ohio (PRWEB) August 27, 2014 ... five students from Cleveland's University School ... at Case Western Reserve University’s School of ... program provides students with an unparalleled professional experience ... with the School of Medicine faculty and students ...
(Date:8/26/2014)... and Bellingham, WA (PRWEB) August 26, 2014 ... engineering, visions for next-generation wearable technology, and inspiration ... numerous highlights at this year’s brighter, busier ... Diego, California, Convention Center. More than 4,400 international ... attended conferences, courses, an exhibition, and industry sessions ...
(Date:8/26/2014)... - A team of engineers from Singapore has ... network (WSN) for satellite communications. , With the ... satellite design, constructing a lightweight, low power-consuming, wireless ... the satellite has always been a challenge for ... Satellite Research Centre of Nanyang Technological University in ...
(Date:8/26/2014)... LONDON , Aug. 26, 2014 An ... gene structures of all Dengue virus strains in Pubmed, ... structures back to 1944. This conservation and sharing of ... a Synthetic Dengue Blocker-Vaccine™ candidate, as it did for ... vaccine, both of which have been found to be ...
Breaking Biology Technology:Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 3Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 4ZigBee in the Sky 2
... Neogen Corporation,(Nasdaq: NEOG ) announced today ... Inc., of Winnipeg, Canada. Rivard Instruments and Neogen,s,subsidiary, ... hypodermic needles., The acquisition settles lengthy litigation ... each. The patent battles were centered,on lawsuits filed ...
... US and Glivec in Europe and Australia) is used ... and gastrointestinal stromal tumors (GISTs). It can be used ... they are caused by related proteins tyrosine kinases. ... means that imatinib can also inhibit tyrosine kinases that ...
... Dec. 3 Thermo Fisher,Scientific Inc. (NYSE: TMO ... the China Doping Control Center (CDCC) has selected the,company ... software for,the testing of athletes at the 29th Olympic ... Chinese government and the International Olympic,Committee (IOC) to conduct ...
Cached Biology Technology:Neogen Acquires Assets of Rivard Instruments 2Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing 2Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing 3Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing 4
(Date:8/25/2014)... of Fire and Emergency Services of Western Australia, a bushfire ... 20 kilometres east of Broome, and Cape Leveque Road approximately ... There is no threat to lives or homes but ... There is a complex of fires burning in the area ... Roadhouse. The fires are also burning on the eastern ...
(Date:8/25/2014)... avoid becoming obese or to slim down if ... groups, maintaining a healthy weight can be that much ... an experimental social psychologist at Rutgers University-Newark. , Rivera ... States to endure negative stereotypes, pervasive messages that suggest ... prevent people from doing what is needed to care ...
(Date:8/25/2014)... , Aug. 25, 2014 /PRNewswire-iReach/ -- Baltimore ... therefore has some of the oldest buildings as well. With these ... arise, one of the most prevalent problems happens to be mold. ... homes in Baltimore and in the walls ... the decades. What can one do though to look for mold ...
Breaking Biology News(10 mins):Racial and ethnic stereotypes may contribute to obesity among minorities 2Mold Concerns in Baltimore 2
... can pollinate themselves and reproduce without the aid of a ... the short-term perks of being able to go it alone ... journal Science . The reason is because plants that ... Flowering plants are incredibly creative when it comes to ...
... be the ultimate green factories, engineered to pump out ... petroleum-based chemicals. But in reality, getting plants to accumulate ... goal. Now, in a first step toward achieving industrial-scale ... (DOE) Brookhaven National Laboratory and collaborators at Dow AgroSciences ...
... A monoclonal antibody targeting a well known cell surface ... aggressive form of the disease that did not respond ... with the UCLA Department of Urology and UCLA,s Jonsson ... the protein, N-cadherin, is up regulated or turned on ...
Cached Biology News:Single parenthood doesn't pay off for plants 2Engineered plants make potential precursor to raw material for plastics 2Engineered plants make potential precursor to raw material for plastics 3UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 2UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 3
...
...
... Formulation: 50mM Tris-HCl, pH 7.5, ... PMSF, 1mM benzamidine, 0.1% 2-mercaptoethanol ... (Protein Phosphatase 2A1) partially purified ... precipitation, QSepharose,amino-hexyl agarose, Superdex 200, ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: